(2026). IL3RA identified as novel biomarker and therapeutic target for ER breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis. Clinical Proteomics.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"IL3RA Identified as Novel Biomarker and Therapeutic Target for ER Breast Cancer Through Plasma Proteome-wide Mendelian Randomization and TCGA Database Analysis."
Clinical Proteomics 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"IL3RA Identified as Novel Biomarker and Therapeutic Target for ER Breast Cancer Through Plasma Proteome-wide Mendelian Randomization and TCGA Database Analysis."
Clinical Proteomics, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.